The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of ZIO-101 in Multiple Myeloma
Official Title: A Phase I/II Trial of ZIO-101 in Advanced Multiple Myeloma
Study ID: NCT00303199
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Little Rock, Arkansas, United States
, West Hollywood, California, United States
, Miami, Florida, United States
, Bethesda, Maryland, United States
, New York, New York, United States
, Cleveland, Ohio, United States
, Edmonton, Alberta, Canada
, Toronto, Ontario, Canada